1,310 results on '"Klein, Reinhild"'
Search Results
2. Autoantibodies targeting G protein-coupled receptors: An evolving history in autoimmunity. Report of the 4th international symposium
3. Increased soluble HLA in COVID-19 present a disease-related, diverse immunopeptidome associated with T cell immunity
4. Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome
5. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
6. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
7. Autoantibodies to beta tubulin in autoimmune liver diseases—Relation to pANCA and clinical relevance.
8. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
9. Autoantibodies to beta tubulin in autoimmune liver diseases - relation to pANCA and clinical relevance
10. The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy
11. Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance
12. CD19-Targeting CAR T Cells for Myositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
13. The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer
14. Figures S1-S5 and Tables S1-S3 from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
15. Data from Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
16. COVID-19 infection after autologous stem cell transplantation for systemic sclerosis
17. Immunology of Uveitis
18. Comparison of cytomegalovirus (CMV)-specific neutralization capacity of hyperimmunoglobulin (HIG) versus standard intravenous immunoglobulin (IVIG) preparations: Impact of CMV IgG normalization
19. Inhibition of effector B cells by ibrutinib in systemic sclerosis
20. A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer
21. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis
22. timsTOF mass spectrometry-based immunopeptidomics refines tumor antigen identification
23. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome.
24. Functional autoantibodies in systemic sclerosis: influence of autologous stem cell transplantation and correlation with clinical outcome
25. Dynamics of Melanoma-Associated Epitope-Specific CD8+ T Cells in the Blood Correlate With Clinical Outcome Under PD-1 Blockade
26. Abstract 2008: The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
27. Recurrent SARS-CoV-2 Infection and Impaired Immunologic Response in a Pediatric Oncologic Patient While Treated With Radiochemotherapy
28. iNKT cells can effectively inhibit IL-6 production by B cells in systemic sclerosis
29. Sulphite oxidase (SO) – a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis
30. Analysis of anti–topoisomerase I antibodies in patients with systemic sclerosis before and after autologous stem cell transplantation
31. Functionally Active Antibodies to the Angiotensin II Type 1-Receptor Measured by a Luminometric Bioassay Do Not Correlate With Clinical Manifestations in Systemic Sclerosis: A Comparison With Antibodies to Vascular Receptors and Topoisomerase I Detected by ELISA
32. Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
33. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity
34. Molekularbiologische Methoden zur HLA-Typisierung
35. Phase I Trial of a Multi-Peptide COVID-19 Vaccine for the Induction of SARS-CoV-2 T-Cell Immunity
36. Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
37. Preexisting and Post–COVID-19 Immune Responses to SARS-CoV-2 in Patients with Cancer
38. Increased Concentrations of Circulating Soluble MHC Class I-Related Chain A (sMICA) and sMICB and Modulation of Plasma Membrane MICA Expression: Potential Mechanisms and Correlation With Natural Killer Cell Activity in Systemic Lupus Erythematosus
39. Expression levels of HLA-DR in acute myeloid leukemia: implications for antigenicity and clinical outcome
40. COVID-19 in Autoinflammatory Diseases with Immunosuppressive Treatment
41. Einfluss einer autologen Stammzelltransplantation auf funktionelle Autoantikörper gegen den Angiotensin Typ 1 Rezeptor bei Patienten mit progressiver systemischer Sklerodermie
42. Defibrotide for the treatment of PIMS-TS in two pediatric patients
43. Vegan diet reduces neutrophils, monocytes and platelets related to branched-chain amino acids – A randomized, controlled trial
44. HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
45. Antibodies to the Muscarinic Acetylcholine Receptor M3 in Primary Biliary Cholangitis Inhibit Receptor Function on Cholangiocytes
46. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia
47. Additional file 1 of Inhibition of effector B cells by ibrutinib in systemic sclerosis
48. SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
49. Defibrotide for the Treatment of Pediatric Inflammatory Multisystem Syndrome Temporally Associated With Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2 Pediatric Patients
50. SARS-CoV-2 T-cell epitopes define heterologous and COVID-19-induced T-cell recognition
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.